Monash and Melbourne researchers uncover mechanism enabling viruses to commandeer human cells
Posted: 7 November 2025 A research team led by Monash University and the University of Melbourne has revealed how small but deadly viruses, such as rabies, manipulate human cells using only a handful of proteins — a discovery…
WEHI led clinical trial receives $1.49 million to test accelerated brain cancer treatment
Posted: 7 November 2025 A new national clinical trial led by the Walter and Eliza Hall Institute of Medical Research (WEHI) has been launched to investigate a faster and less burdensome treatment for people with glioblastoma, the most…
PureCDM appoints Michael Fitzgerald as Director of Biostatistics for Asia-Pacific
Posted: 6 November 2025 PureCDM has announced the appointment of Michael Fitzgerald as Director of Biostatistics for the Asia-Pacific region, marking a key milestone in the company’s continued investment in biostatistical leadership and scientific excellence. With more than…
Noxopharm advances to second phase of HERACLES clinical trial
Posted: 6 November 2025 Noxopharm Limited announced it had commenced the second part of its HERACLES clinical trial, following the successful completion of single-dose testing of its novel autoimmune therapy candidate, SOF-SKN™. Chief Executive Officer Dr Gisela Mautner…
Radium Capital surpasses $1 billion in funding milestone
Posted: 5 November 2025 Radium Capital has reached a major milestone, surpassing $1 billion in innovation funding since its founding in 2017 – a benchmark that Managing Director Jeremy Loftus said highlighted that R&D finance is a cornerstone…
Myrio Therapeutics joins Penn Medicine and NYU Langone in collaboration to advance solid tumor T cell immunotherapies
Posted: 28 October 2025 A new international collaboration between Myrio Therapeutics, the University of Pennsylvania’s Perelman School of Medicine, and NYU Langone Health has been formed to accelerate the development of next-generation T cell immunotherapies targeting solid tumours.…
MTPConnect signs cooperation agreement with Saudi Ministry of Health to boost collaboration
Posted: 28 October 2025 MTPConnect has formalised a new partnership with the Saudi Ministry of Health through the signing of a Memorandum of Understanding (MoU) at the Global Health Exhibition 2025 in Riyadh. The agreement, signed by MTPConnect…
RMIT University develops cancer-targeting nanodots in international breakthrough
Posted: 27 October 2025 An international research collaboration led by RMIT University has developed tiny metallic particles that selectively kill cancer cells while leaving healthy tissue largely unharmed, marking a promising advance in the design of future cancer…
Telix agent Zircaix® featured in global guidelines for renal imaging
Posted: 24 October 2025 Telix Pharmaceuticals has announced that its investigational PET imaging agent TLX250-CDx (Zircaix®, ⁸⁹Zr-DFO-girentuximab) has been included for the first time in international clinical guidelines for molecular imaging of renal masses. Kevin Richardson, Chief Executive…
Swinburne and partners pioneer AI-driven model to advance precision medicine in muscular dystrophy
Posted: 24 October 2025 A world-first AI-powered disease progression model for facioscapulohumeral muscular dystrophy (FSHD) has been developed through a collaboration between Swinburne University of Technology, the FSHD Global Research Foundation, the National Imaging Facility (NIF), and Springbok…
Immuron launches PROIBS® in Australia
Posted: 24 October 2025 Immuron has officially launched PROIBS®, a new product designed to relieve symptoms of medically diagnosed Irritable Bowel Syndrome (IBS), into the Australian market. The biopharmaceutical company confirmed that pharmacy orders had already been received…
Noxopharm secures first US patent for Sofra™
Posted: 23 October 2025 Noxopharm Limited (ASX:NOX) announced that it had been granted its first United States patent for the company’s Sofra™ technology platform, marking a key milestone in its expanding oncology research portfolio. The patent, issued by…
